Division of Pediatric Infectious Diseases

October 26, 2023

Karen Bloch honored for clinical excellence by Infectious Diseases Society of America

Vanderbilt’s Karen Bloch, MD, MPH, is one of two winners of the 2023 Watanakunakorn Clinician Award from the Infectious Disease Society of America.

By Paul Govern
August 15, 2023

Study finds most infants receiving ICU-level care for RSV had no underlying medical condition

A Vanderbilt study found that most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term.

By Jessica Pasley
Recipients of the 2023 Research Staff Awards are, front row from left, Laura Stevens, MS, Kate Von Wahlde, MJ, CCRP, and JoAnn Gottlieb, RDMS, RDCS. Presenting the awards were, back row from left, Jennifer Pietenpol, PhD, Gordon Bernard, MD, and John Kuriyan, PhD.
April 6, 2023

Research Staff Awards honor contributions to discovery

By Bill Snyder
March 2, 2023

High-dose flu vaccine beneficial for pediatric stem cell transplant patients

Vanderbilt was the lead site for an influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population.

By Jessica Pasley
Kathryn Edwards, MD, spoke at a recent event celebrating her career.
January 5, 2023

Infectious disease expert Edwards ends storied career

Vanderbilt’s Kathryn Edwards, MD, internationally recognized for her countless contributions to vaccine evaluation and implementation, public health advocacy, and the mentorship and training of new generations of experts in infectious disease over the past four decades, retired on Dec. 31, 2022.

By Nancy Humphrey
November 17, 2022

Improving awareness and understanding of antimicrobial resistance is crucial

The Vanderbilt Antimicrobial Stewardship Program provides oversight of antimicrobial therapies for both inpatient and outpatient populations.

By Jessica Pasley
July 28, 2022

Study to evaluate nasal flu vaccine for children

Pediatricians with the Vanderbilt Vaccine Research Program are looking for healthy infants and children (6 months – 8 years of age) to take part in a nasal influenza vaccine study.
By Craig Boerner
March 7, 2022

Teen shares his battle with MIS-C following COVID-19 infection

Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.
By Christina Echegaray
December 7, 2021

VUMC awarded CDC funding to combat antimicrobial resistance, infectious diseases

Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).
By Jessica Pasley
October 21, 2021

Study explores impact of COVID-19 on children

By Jessica Pasley
February 8, 2021

Monroe Carell Jr. Children’s Hospital at Vanderbilt sees surge in rare MIS-C cases amid drop in COVID-19 numbers

While the number of COVID-19 cases across the country is decreasing, pediatricians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are beginning to see a new post-surge trend: an increase in cases of multi-system inflammatory syndrome in children (MIS-C).
By Christina Echegaray
July 14, 2020

VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial

An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.
By Leigh MacMillan